Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease

Contenu

Click for External Resource*

https://www.ncbi.nlm.nih.gov/pubmed/25991468

Click to read full article*

https://academic.oup.com/cid/article/61/6/969/450746

The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.

Files for Download

Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease

http://repository.netecweb.org/pdfs/civ395.pdf

Item Type

Publication

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Voir les documents

Share this page:

Facebook Twitter Adresse de messagerie

Was this resource helpful?

Titre

Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease

Sujet

Research

Description

From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa.

Créateur

Florescu, D. F., A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith

Date

2015-09-15

Type

Publication

Citer ce document

Florescu, D. F., A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith (2015). "Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease." Clin Infect Dis 61(6): 969-973.

Résumé

From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.